Haines Ely, M.D.
|Haines Ely M.D. has been teaching residents at UC Davis since 1975 (before there was a full time Department of Dermatology). He is particularly interested in dermatologic therapy and has lectured on the most recent advances in therapy all over this country as well as in Europe and Australia. In 1996 he spoke on "What's new in dermatologic therapy" at the American Academy of Dermatology annual meeting in Washington, D.C. His topic was "Tumor necrosis factor inhibition in dermatologic disease." This was years before our current biological TNF inhibitors were discovered. At the same meeting he proposed using the sap of the Euphorbia peplus plant as a skin cancer remedy. It is now on the market and commercially available. He loves to see the most difficult cases with our residents and often comes up with novel therapies for untreatable conditions. He also has a special interest in teledermatology applications here at UC Davis and sees patients in the Telemedicine Department two days a week.|
Title: Associate Physician
Undergraduate Education: Stanford University, Stanford, CA, A.B., 1967
Medical Education: University of Southern California, Los Angeles, CA, M.D., 1971
Internship: University of Southern California/Los Angeles County Medical Center, Los Angeles, CA, Medical Center, Straight Medicine 1971-72.
Residency: University of Southern California/Los Angeles County Medical Center, Los Angeles, CA, Medical Center 1972-75
July 17, 1971 California G22469
Qualified Medical Evaluator QME No. 914606
CLIA No. 05D0686635
American Board of Dermatology, 1976
American Board of Dermatology and American Board of Pathology, Dermatopathology, 1980
Clinical Professor of Dermatology, U.C. Davis, 1975-2007
Professor, Department of Dermatology, UC Davis, 2007-
Nelson Paul Anderson Memorial Essay, First place
Pacific Dermatological Society, 1979
Mini Presentation of the year. PDA ,1984
President’s award for excellence in teaching, U.C. Davis, 1987
Teacher of the year award, UC Davis, 2007
President, Sacramento Valley Dermatological Society, 1990-91
Board of Directors Placer Nevada Medical Society 1981-3, 1991-93, 1998- 2007
Vice president 1994,
President , Placer Nevada Medical Society, 1995
Board of Directors, Tri-County American Cancer Society, 1978-79. 1991-1992.
Medical Council, The Skin Cancer Foundation, 1987-
Board of Directors, Medical Care Foundation, Sacramento, 1986-89.
Board of Directors, Nevada City Winery, 1988- 1996, 2000 -
Host of the weekly radio show, "Earth Mysteries", KVMR 89.5 FM, 1986-
Alternate Delegate, California Medical Association 1995-1997
Delegate, 11th district, CMA, 2007-
CMA representative to the California Telehealth/Telemedicine Coordination Project Planning Committee 1996-2000
CMA Technical Advisory Committee on Telemedicine 1996-2000
AAD Task force on Nutrition and Alternative
Medicine in Dermatology 1997
Chief of Service, Dermatology, Sierra Nevada Memorial Hospital 2002-
Assistant Editor, Journal of the American Academy of Dermatology, 1988-1994
Editorial Board "California Physician" 1994-1998
Editorial Board "Cutis" 1996-
Editorial Board "Dermatology Online" 2000-
Manuscript reviewer: JAAD, 1980-
Archives of Internal Medicine, 1988-
Annals of Internal Medicine, 1980-
Archives of Dermatology, 1977-
Societies: American Academy of Dermatology (Fellow)
American Society of Dermatopatholgy (Fellow)
California Medical Association
American Medical Association
Pacific Dermatologic Association
Noah Worcester Dermatological Society
North American Clinical Dermatologic Society
Cutaneous Therapy Society
American Society for Dermatologic Surgery
International Society for Tropical Dermatology
American Federation for Clinical Research
The Society of Investigative Dermatology
The Royal Society of Medicine (London)
The Dermatology Foundation
Space Dermatology Foundation (Founding Member)
Shivas Irons Society (Founding member)
International Society of Dermatopathology
United States Patent:
5,196,448 March 23, 1993 (Antiinflammatory compositions and method of use: esters of silybin with dicarboxylic acids)
Ely, H, Pascucci, A, Merkel Cell Carcinoma; Treatment with Bleomycin, 2008, Dermatology Online Journal
Rigel, D, Torres, AM, Ely, H, Imiquimod 5% Cream Following Curettage without Electrodessication for Basal Cell Carcinoma: Three Year Follow Up, 2008
Rigel,D, Torres, AM, Ely, H, Imiquimod 5% Cream Following Curettage Without Electrodesiccation for Basal Cell Carcinoma: Preliminary Report, J Drugs Dermatol. 2008;7(1) Supplement; s15-s16
Rigel, D, Ely, H, Torres, A, et al., Effectiveness of Curettage and Imiquimod 5% Cream in the Treatment of Basal Cell Carcinoma; Clinical and Cosmetic Evaluation, Poster Presentation, American Academy of Dermatology Annual Meeting, San Francisco, 2006
Ely, H., The Bowel Bypass Syndrome, in Clinical Dermatology, Demis, JD, Dobson, RL, Mcguire, J, Thiers, B., eds., Lippincott-Raven, Philadelphia, 1998
Ely, H. Human Phenotypes. The Atopic and Seborrheic: Part III, Cutis, 1997:59(2): 67-70
Ely, H. Human Phenotypes. The Atopic and Seborrheic: Part II, Cutis, 1997: 59(1): 13-18
Ely, H., Human Phenotypes: The atopic and seborrheic: Part I, Cutis, 1996: 58(1) 27-31.
Ely, H., What’s new in telemedicine, California Physician, 1996; 13(10):45
Ely, H., Dermatologists Deserve a Break, California Physician,1996;13(4):12
Ely, H., Physicians on the Internet, California Physician, 1995: 12(10) 35-40.
Ely, H., The Hubris of Some Gatekeepers, (Editorial) California Physician, 1995: 12(3): 17.
Ely, H., Drug Eruption Reference Manual, (Book Review), J Amer Acad Dermatol 1995; 33: 146
Ely, H., Is Pentoxifylline the Drug of the Decade? (Editorial) J. Amer. Acad. Dermatol. 1994:30(4):639-42.
Ely, H., Herbs Useful in Dermatologic Therapy (Book Review), J. Amer. Acad. Dermatol 1994; 31: 520
Ely, H., Recent Developments in Dermatologic Uses of Cyclosporin and Amelioration of Renal Toxicity with Pentoxifylline, (Review), Current Opinion in Dermatology, 1993:223-230.
Ely, H., Surgical Elyisms, Clinics in Dermatology, 1992: 10: 381-85.
Ely, H., Shocking Therapy: Uses of Transcutaneous Electric Nerve Stimulation in Dermatology, Dermatologic Clinics, 1991:9(1):189-97.
Ely, H., Chronic Urticaria: Treatment with H2 Receptor Antagonists, JAMA, 1988:259:2467.
Ely, H., White Blood Cells as Mediators of Hyperviscosity-Induced Tissue Damage in Neutrophilic Vascular Reactions: Therapy with Pentoxifylline, J. AM. Acad. Dermatol., 1989: 20(4): 677-680.
Ely, H., Therapies You’ve Probably Never Heard Of, Dermatologic Clinics, 1989: 7(1): 19-35.
Ely, P.H. and Bard, J.W., Therapy of Livedo Vasculitis with Pentoxifylline, Cutis, 1988: 42: 448-453.
Ely, P.H., Pentoxifylline Therapy in Dermatology: A Review of Localized Hyperviscosity and Its Effects on the Skin, Dermatologic Clinics, 1988: 6(4): 585-608.
Ely, P.H., and Thiers, B., eds, Dermatologic Therapy, (2 Volumes) Dermatologic Clinics, W.B. Saunders Co., Philadelphia, 1988 Vol 6(4), 1989 Vol 7(1).
Ely, P.H., Localized Hyperviscosity Syndromes, Hoechst Pharma, 1988:15:54.
Ely, P.H., Pathogenesis of the Bowel Bypass Syndrome (Review), in Pathogenesis of Skin Disease, Dobson, R.L., and Thiers, B. eds, Churchill Livingston, N.Y., 1986. pp 281-305.
Ely, P.H., Vermillionectomy, J Derm. Surg. and Oncol. 1984: 10(3):167.
Ely, P.H., Eczema: A Dialogue, Am. J. Derm. Path., 1983:5(5)413.
Ely, P.H., The Bowel Bypass Syndrome, in Clinical Dermatology, Demis, J.D., Dobson, R.L., McGuire, J., Thiers, B., eds. , Harper and Rowe, Philadelphia, 1984.
Ely, P.H., Immunopathology of the Bowel Bypass Syndrome, in Immunodermatology, D.M. MacDonald, ed., Butterworth and Co., London, 1984. 287-89.
Ely, P.H., "Clinical Research", in Controversies in Dermatology, E. Epstein, ed., W.B. Saunders Co., Philadelphia, 1984:453-57.
Ely, H., "New England Society of Allergy Proceedings National Symposium on Aspirin and Endogenous Mediators of Disease" (Book Review) J. Am. Acad. Dermatol.,1982: 6:282-83.
Ely, P.H., Treatment of Skin Carcinoma of the Face and Neck, JAMA: 1982:247(6):754.
Utsinger, P., Farber,N., Shapiro, R., Ely, P.H., McLaughlin, G.E., Weisner, K.B., Clinical and Immunologic Study of the Post-Intestinal Bypass Arthritis-Dermatitis Syndrome, Arth. Rhuem., 1978:12:599.
Ely, P.H., and Utsinger, P. Clinical Observations and Immunologic Abnormalities Following Bowel Bypass Surgery, J. Amer. Acad. Dermatol., 1980: 2: 529-30.
Ely, P.H., The Bowel Bypass Syndrome: A Response to Bacterial Peptidoglycans, J. Amer. Acad. Dermatol., 1980:2:473-87.
Ely, P.H., Skin Lesions and Arthritis Associated with Ileojejunal Shunt Surgery: A Possible Peptidoglycan Antigen Disease, Arch. Derm., 1978:114:1831.
Ely, P.H., Balance Beam Alopecia, Arch Derm. 1978:114:968
Ely, P.H., More on Skin Closures, Arch Derm, 1978:114:125.
Ely, P.H., Rasheed, S., Rongey, R., Cytopathic Effects Produced by Non-Replicating Human Wart Virus in Vitro, Clin Research, 1975:23:90A.
To schedule an appointment and to see if Dr. Ely is accepting new patients please call: 916-734-6111.